Global epidemiology of


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
03 2021
Historique:
received: 05 04 2020
accepted: 14 04 2020
pubmed: 20 5 2020
medline: 24 4 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

To provide an in-depth systematic assessment of the global epidemiology of gonorrhoea infection in infertile populations. A systematic literature review was conducted up to 29 April 2019 on international databases and WHO regional databases, and reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. All prevalence measures of gonorrhoea infection among infertile populations, based on primary data, qualified for inclusion. Infertile populations were broadly defined to encompass women/men undergoing infertility evaluation or treatment (infertility clinic attendees and partners). Pooled mean prevalence by relevant strata was estimated using random-effects meta-analysis. Associations with prevalence and sources of heterogeneity were explored using metaregression. Risk of bias was assessed using four quality domains. A total of 147 gonorrhoea prevalence studies were identified from 56 countries. The pooled mean prevalence of current gonorrhoea infection was estimated globally at 2.2% (95% CI 1.3% to 3.2%), with the highest prevalence in Africa at 5.0% (95% CI 1.9% to 9.3%). The mean prevalence was higher for populations with tubal factor infertility (3.6%, 95% CI 0.9%-7.7%) and mixed cause and unexplained infertility (3.6%, 95% CI 0.0% to 11.6%) compared with other diagnoses, such as ovarian and non-tubal infertility (0.1%, 95% CI 0.0% to 0.8%), and for secondary (2.5%, 95% CI 0.2% to 6.5%) compared with primary (0.5%, 95% CI 0.0% to 1.7%) infertility. Metaregression identified evidence of variations in prevalence by region and by infertility diagnosis, higher prevalence in women than men and a small-study effect. There was a trend of declining prevalence by about 3% per year over the last four decades (OR=0.97, 95% CI 0.95 to 0.99). Gonorrhoea prevalence in infertile populations is several folds higher than that in the general population, with even higher prevalence in women with tubal factor infertility and in individuals with secondary infertility. These findings support the potential role of gonorrhoea in infertility and suggest that some infertility is possibly preventable by controlling gonorrhoea transmission. CRD42018102934.

Identifiants

pubmed: 32423944
pii: sextrans-2020-054515
doi: 10.1136/sextrans-2020-054515
pmc: PMC7892374
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-169

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: The authors have no conflicts of interests to declare.

Références

Sex Transm Dis. 2009 Aug;36(8):478-89
pubmed: 19617871
Sex Transm Infect. 2018 Aug;94(5):372-376
pubmed: 29203577
Sex Transm Infect. 1999 Aug;75 Suppl 1:S2-3
pubmed: 10616371
Microb Cell. 2019 Jan 24;6(3):177-183
pubmed: 30854394
Can J Infect Dis Med Microbiol. 2005 Jan;16(1):15-25
pubmed: 18159523
Hum Reprod. 1998 Apr;13(4):1094-8
pubmed: 9619578
Psychosom Med. 2004 May-Jun;66(3):411-21
pubmed: 15184705
Vaccine. 2020 Jun 9;38(28):4362-4373
pubmed: 32359875
PLoS Pathog. 2014 Aug 07;10(8):e1004111
pubmed: 25101790
Microb Cell. 2016 Sep 05;3(9):371-389
pubmed: 28357376
Andrologia. 2008 Apr;40(2):72-5
pubmed: 18336453
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Sex Transm Dis. 2016 Dec;43(12):725-730
pubmed: 27835623
Sci Rep. 2018 Jan 26;8(1):1661
pubmed: 29374178
J Med Life. 2015 Apr-Jun;8(2):129-31
pubmed: 25866566
Am J Obstet Gynecol. 2017 Jan;216(1):1-9
pubmed: 28007229
Sex Transm Infect. 2012 Aug;88(5):317-8
pubmed: 22798629
Clin Microbiol Rev. 2015 Oct;28(4):969-85
pubmed: 26310245
Fertil Steril. 2017 Sep;108(3):393-406
pubmed: 28760517
N Engl J Med. 2005 Feb 17;352(7):676-85
pubmed: 15716561
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
N Engl J Med. 2012 Feb 9;366(6):485-7
pubmed: 22316442
Curr Opin Infect Dis. 2014 Feb;27(1):62-7
pubmed: 24275696
Sci Rep. 2019 Feb 4;9(1):1136
pubmed: 30718696
Bull World Health Organ. 2010 Dec 1;88(12):881-2
pubmed: 21124709
Sex Transm Dis. 2000 Jul;27(6):343-9
pubmed: 10907910
Bull World Health Organ. 2019 Aug 1;97(8):548-562P
pubmed: 31384073
Curr Opin Infect Dis. 2018 Jun;31(3):246-250
pubmed: 29601324
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
Sex Transm Dis. 2001 Feb;28(2):117-23
pubmed: 11234786
Hum Reprod Update. 2015 Jul-Aug;21(4):411-26
pubmed: 25801630
Genitourin Med. 1994 Aug;70(4):273-7
pubmed: 7959714
Am Fam Physician. 2009 Apr 1;79(7):583-7
pubmed: 19378875
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19
pubmed: 27414503
Hum Reprod Update. 2011 May-Jun;17(3):301-10
pubmed: 21227996
PLoS Med. 2012;9(12):e1001356
pubmed: 23271957
Fertil Steril. 1997 Aug;68(2):205-13
pubmed: 9240243
Antibiotics (Basel). 2018 Jun 15;7(2):
pubmed: 29914071
Sex Transm Infect. 2004 Dec;80 Suppl 2:ii8-12
pubmed: 15572645
Lancet Infect Dis. 2016 Sep;16(9):1057-1064
pubmed: 27289389
Int J STD AIDS. 2010 Apr;21(4):277-8
pubmed: 20378901
Reprod Biol Endocrinol. 2015 Apr 26;13:37
pubmed: 25928197
Sex Transm Infect. 2014 May;90(3):254-6
pubmed: 24448560
Int J Womens Health. 2011;3:197-206
pubmed: 21845064
AIDS. 2018 Jun 19;32(10):1343-1352
pubmed: 29794495
BMC Womens Health. 2004 Aug 25;4 Suppl 1:S26
pubmed: 15345089
J Pathog. 2016;2016:4698314
pubmed: 27047692
BMJ Open. 2019 May 22;9(5):e025808
pubmed: 31122971
Epidemics. 2010 Dec;2(4):173-82
pubmed: 21352788
Expert Rev Anti Infect Ther. 2014 Jun;12(6):657-72
pubmed: 24484215
MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19
pubmed: 24622331
Arch Sex Behav. 2017 Feb;46(2):419-432
pubmed: 26940966
Hum Reprod. 2006 Nov;21(11):2911-5
pubmed: 16832124
J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1308-11
pubmed: 22541067
Fertil Steril. 2011 Mar 1;95(3):915-21
pubmed: 21130988
Sex Transm Dis. 1998 Sep;25(8):437-42
pubmed: 9773439
Perspect Sex Reprod Health. 2008 Dec;40(4):218-25
pubmed: 19067935
PLoS Med. 2014 Jun 17;11(6):e1001663
pubmed: 24937136
Sex Health. 2014 Dec;11(6):556-60
pubmed: 25435192
Lancet Glob Health. 2019 Sep;7(9):e1197-e1225
pubmed: 31402004
PLoS One. 2015 Dec 08;10(12):e0143304
pubmed: 26646541
Int J STD AIDS. 2002 Feb;13(2):91-101
pubmed: 11839163
Epidemiol Infect. 2014 Nov;142(11):2422-32
pubmed: 25267407
Future Microbiol. 2015;10(1):35-51
pubmed: 25598336
Sex Transm Dis. 2020 Mar;47(3):151-157
pubmed: 31880741
Clin Infect Dis. 2019 Feb 15;68(5):757-772
pubmed: 30020453
Sex Transm Dis. 2009 Feb;36(2 Suppl):S62-6
pubmed: 18418303
AIDS. 2017 Jul 31;31(12):1721-1732
pubmed: 28514276
Front Immunol. 2018 Nov 21;9:2710
pubmed: 30524442
Sex Transm Dis. 2016 Mar;43(3):139-46
pubmed: 26859800
Sex Transm Infect. 2000 Apr;76(2):80-7
pubmed: 10858707
J Adolesc Health. 2009 Sep;45(3):303-9
pubmed: 19699429
Clin Infect Dis. 2019 Oct 15;69(9):1621-1623
pubmed: 30778532
Reprod Health Matters. 2012 Dec;20(40):76-82
pubmed: 23245412
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):813-821
pubmed: 28013414

Auteurs

Hiam Chemaitelly (H)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar hsc2001@qatar-med.cornell.edu toskini@who.int lja2002@qatar-med.cornell.edu.

Alzahraa Majed (A)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.

Farah Abu-Hijleh (F)

Department of Public Health, College of Health Sciences, Academic Quality Affairs Office, QU Health, Qatar University, Doha, Qatar.

Karel Blondeel (K)

Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Thabo Christopher Matsaseng (TC)

Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Department of Obstetrics & Gynaecology, Stellenbosch University, Stellenbosch, South Africa.

James Kiarie (J)

Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Igor Toskin (I)

Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland hsc2001@qatar-med.cornell.edu toskini@who.int lja2002@qatar-med.cornell.edu.

Laith J Abu-Raddad (LJ)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar hsc2001@qatar-med.cornell.edu toskini@who.int lja2002@qatar-med.cornell.edu.
Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH